You are here

Paul Hudson

A year into Sanofi's revamp, CEO Paul Hudson collects €11.34M in 2020 pay—including that signing bonus

A year into Sanofi's revamp, CEO Paul Hudson collects €11.34M in 2020 pay—including that signing bonus

Fierce Pharma

Flag link:

Paul Hudson faces down French unions in fight to restructure Sanofi

Paul Hudson faces down French unions in fight to restructure Sanofi

Endpoints

Flag link:

Sanofi has a name for its ingredients spinoff, taps Centrient head Karl Rotthier as first CEO

Sanofi has a name for its ingredients spinoff, taps Centrient head Karl Rotthier as first CEO

Endpoints

Flag link:

Doubling down on Sanofi's French roots, Paul Hudson infuses €50M into Jeito Capital to boost homegrown biotechs

Doubling down on Sanofi's French roots, Paul Hudson infuses €50M into Jeito Capital to boost homegrown biotechs

Endpoints

Flag link:

Sanofi, despite COVID-19, sees early gains from CEO Hudson's strategy revamp

Sanofi, despite COVID-19, sees early gains from CEO Hudson's strategy revamp

Fierce Pharma

Flag link:

Paul Hudson is more confident in Sanofi's ability to produce a Covid-19 vaccine — report

Paul Hudson is more confident in Sanofi's ability to produce a Covid-19 vaccine — report

Endpoints

Flag link:

Sanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project

Sanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project

Fierce Pharma

Flag link:

COVID-19 vaccine row escalates as Macron calls meeting with Sanofi’s CEO

COVID-19 vaccine row escalates as Macron calls meeting with Sanofi’s CEO

Pharmaforum

Flag link:

Sanofi CEO courts controversy after saying US is first in line for COVID-19 vaccine

Sanofi CEO courts controversy after saying US is first in line for COVID-19 vaccine

Pharmaforum

Flag link:

Sanofi CEO cautions arthritis drug a 'long shot' in COVID-19, says study results 'imminent'

Sanofi CEO cautions arthritis drug a 'long shot' in COVID-19, says study results 'imminent'

BioPharma Dive

clinical trials

Flag link:

Sanofi CEO Hudson continues crusade for European pandemic muscle

Sanofi CEO Hudson continues crusade for European pandemic muscle

Fierce Pharma

Flag link:

With Kevzara in COVID-19 testing, Sanofi and Regeneron won't divvy up their rights

With Kevzara in COVID-19 testing, Sanofi and Regeneron won't divvy up their rights

Fierce Pharma

Flag link:

Sanofi CEO: Amid COVID-19 supply push, one fever means 'maybe a half dozen' workers off the job

Sanofi CEO: Amid COVID-19 supply push, one fever means 'maybe a half dozen' workers off the job

Fierce Pharma

hydroxychloroquine

drug manufacturing

Flag link:

Will Eczema Drug Dupixent Transform Sanofi?

Will Eczema Drug Dupixent Transform Sanofi?

Motley Fool

Flag link:

Sanofi Slims Top Executive Ranks as New CEO Paul Hudson Revamps Strategy

Sanofi Slims Top Executive Ranks as New CEO Paul Hudson Revamps Strategy

Bloomberg

Flag link:

Stop and plan it out: Sanofi CEO Paul Hudson offers up advice for digitally ambitious pharmas

Stop and plan it out: Sanofi CEO Paul Hudson offers up advice for digitally ambitious pharmas

Fierce Pharma

Flag link:

Sanofi CEO Hudson backs away from struggling diabetes, cardiovascular areas in strategy unveiling

Sanofi CEO Hudson backs away from struggling diabetes, cardiovascular areas in strategy unveiling

Fierce Pharma

cardiovascular death

Flag link:

New Sanofi CEO Looks to Shake Things Up

New Sanofi CEO Looks to Shake Things Up

Yahoo/Guru Focus

Flag link:

‘There are moments’: Sanofi’s new CEO is thinking through the R&D strategy — and oncology will be key

‘There are moments’: Sanofi’s new CEO is thinking through the R&D strategy — and oncology will be key

Endpoints

Flag link:

New Sanofi CEO Paul Hudson embarks on fact-finding journey. What's his next move?

New Sanofi CEO Paul Hudson embarks on fact-finding journey. What's his next move?

Fierce Pharma

Flag link:

Pages